Panacea Proposers Day
December 14, 2018, 10:00 AM ET
The Biological Technologies Office is holding a Proposers Day to provide information on the structure and objectives of the Panacea program. Panacea aims to integrate systems pharmacology and advanced medicinal chemistry approaches to expand the human drug target space for therapeutic interventions in the areas of acute management of pain and inflammation and the improvement of physiological endurance under oxygen-limited conditions or environments. Panacea will support the development and proof-of-concept demonstration of a new integrated platform for the rapid prediction, synthesis, and validation of pharmacological interventions.
Artificial Intelligence Colloquium
March 6-7, 2019
DARPA has long been a leader in the field of artificial intelligence, establishing the foundations of the field and leading creation of expert systems, and then supporting the expansion of machine learning. The agency’s most recent investments — undertaken as part of DARPA’s $2 billion AI Next campaign — are supporting a shift in AI systems from tools alone to trusted, collaborative partners in problem solving. To increase awareness of DARPA’s expansive AI R&D efforts, the agency is hosting an Artificial Intelligence Colloquium (AIC) in March 2019. The event will bring together the Department of Defense research community and stakeholders to learn more about DARPA’s current and emerging AI programs, and discover how the technologies in development could apply to diverse missions.